Last annual meeting of POC-HCV

in Paris, on July 4th 2016. This meeting gathered all PoC-HCV partners, in the presence of invitees and the members of the Independent Advisory Board of the project, who carefully advised in the project planned activities and outcomes. The project will be finished on August 31st.  

Successful External Assessment of Genedrive® Hepatitis C Test

Partner 3 EPISTEM has announced on February 18th that its Genedrive® point of care Hepatitis C ("HCV") test has successfully completed its first external assessment.The assessment was conducted on reference material and patient samples at the Institut Pasteur, Paris, and its success allows clinical trials of the HCV test to commence, in anticipation of regulatory approval and market launch in the EU during 2017.

For more information: Epistem 

 

2nd Annual meeting of PoC-HCV

in Manchester, on October 2nd-1st 2015. This meeting gathered all PoC-HCV partners, in the presence of invitees and the members of the Independent Advisory Board of the project, who carefully advised in the project planned activities. 

EASL 2015 conference, Vienna April 22-26

Meet the project partners and see PoC tests in action at the EASL 2015 conference, Vienna April 22-26

1st Annual meeting of PoC-HCV

in Lund, on October 2nd-1st 2014. This meeting gathered all PoC-HCV partners, in the presence of invitees and the members of the Independent Advisory Board of the project, who carefully advised in the project planned activities. 

PoC-HCV survey online

We are seeking feedback from people treating HCV patients. Please answer to our survey here!

The International Liver Congress™ EASL 2014, London

The PoC-HCV project will be promoted at the EASL congress on 10-11 April 2014 with project partners. Come visit us at booth n° 113! http://www.ilc-congress.eu/

2nd Annual Symposium ITMO Public Health December 5, 2013

Integrating genetic and functional biomarkers using Point-of-Care diagnostic tools, National Library of France (BNF), Paris, Matthew Albert (Institut Pasteur/Inserm U818, Paris); http://www.aviesan.fr/en/aviesan/home/aviesan-news/2nd-annual-conference-of-the-public-health-thematic-multi-organization-institute-itmo-personalized-medicine-and-biomedical-innovations-public-health-economic-ethical-and-social-challenges/%28sort_cat%29/3731

EASL Monothematic Conference November 30, 2013

Translational Research in Chronic Viral Hepatitis - Bridging Basic Science and Clinical Research, Lyon, France, "HCV Prediction of Disease/Treatment Outcome", Matthew Albert (Institut Pasteur/Inserm U818, Paris); http://events.easl.eu/EventPortal/Information/MLYON2013/HOME.aspx

Journée de Recherche Translationnelle, October 18th, 2013

Institut Pasteur, Paris, France “HCV biomarkers: from discover to utilization”, Darragh Duffy (Institut Pasteur/Inserm U818, Paris).


europe  

PoC-HCV is a European research project supported
by the European Commission (Grant agreement n° 601851).